Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Diethylamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 1/20 | 0.33 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.32 |
| ▸ | MAPKAPK2 | P49137 | 1/20 | 0.30 |
| ▸ | SYK | P43405 | 1/20 | 0.30 |
| ▸ | EGFR | P00533 | 1/20 | 0.30 |
| ▸ | ITK | Q08881 | 1/20 | 0.30 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.30 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.30 |
| ▸ | LCK | P06239 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6059174 | 0.96 | PPARG (0.34) | PPARGMKNK2MAPKAPK2SYKEGFR | |
| Diethylamine SCHEMBL7377252 | 0.89 | L3MBTL1 (0.36) | PPARGMKNK2MAPKAPK2 | |
| SCHEMBL6059420 | 0.84 | L3MBTL1 (0.38) | PPARGMKNK2MAPKAPK2 | |
| SCHEMBL6058797 | 0.79 | PPARG (0.36) | PPARGMKNK2LCK | |
| Diethylamine SCHEMBL7380494 | 0.79 | NAMPT (0.41) | PPARGMKNK2MAPKAPK2PTGDR2 | |
| SCHEMBL6059338 | 0.78 | LCK (0.40) | MAPKAPK2SYKPTGDR2MAPK14LCK | |
| SCHEMBL6058628 | 0.78 | PPARG (0.39) | PPARGMKNK2PTGDR2 | |
| SCHEMBL6059191 | 0.77 | MAP4K4 (0.35) | MAPKAPK2SYKEGFRMAPK14LCK | |
| Malonic Acid Diethyl Ester SCHEMBL7380431 | 0.76 | PPARG (0.36) | PPARGMKNK2 | |
| SCHEMBL3820976 | 0.74 | NAMPT (0.43) | PPARGMKNK2PTGDR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1180098-A1 | NEW COMPOUNDS | AstraZeneca AB (SE) | 2002-02-20 | — | — | EP | disclosed |
| WO-2000066557-A1 | NEW COMPOUNDS | ASTRAZENECA AB (SE) | 2000-11-09 | — | — | WO | disclosed |